Algenex
About:
Algenex is a developer of vector-based innovative technologies designed to manufacture recombinant proteins.
Website: http://www.algenex.com/
Top Investors: Cleon Capital, Vita Advisory
Description:
Algenex is a developer of vector-based innovative technologies designed to manufacture recombinant proteins. The company's technologies use a baculovirus expression vector system for vaccine manufacturing, diagnostic reagents, crystallography, HTS and therapeutic molecules.
Total Funding Amount:
4M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Pozuelo De Alarcón, Madrid, Spain
Founded Date:
2005-01-01
Contact Email:
administracion(AT)algenexcvt.cluster027.hosting.ovh.net
Founders:
José Ángel Escribano
Number of Employees:
1-10
Last Funding Date:
2019-03-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai